{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:37:48Z","timestamp":1790800668194,"version":"4.1.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,31]],"date-time":"2018-10-31T00:00:00Z","timestamp":1540944000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s00702-018-1934-9","type":"journal-article","created":{"date-parts":[[2018,10,31]],"date-time":"2018-10-31T07:23:25Z","timestamp":1540970605000},"page":"65-85","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Clinical implications of APOE genotyping for late-onset Alzheimer\u2019s disease (LOAD) risk estimation: a review of the literature"],"prefix":"10.1007","volume":"126","author":[{"given":"Victoria S.","family":"Marshe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilona","family":"Gorbovskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Kanji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxine","family":"Kish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,31]]},"reference":[{"key":"1934_CR1","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1177\/0022146514555982","volume":"55","author":"R Almeling","year":"2014","unstructured":"Almeling R, Gadarian SK (2014) Reacting to genetic risk: an experimental survey of life between health and disease. J Health Soc Behav 55:482\u2013503","journal-title":"J Health Soc Behav"},{"key":"1934_CR2","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1080\/10810730903295518","volume":"14","author":"S Ashida","year":"2009","unstructured":"Ashida S, Koehly LM, Roberts JS et al (2009) Disclosing the disclosure: factors associated with communicating the results of genetic susceptibility testing for Alzheimer\u2019s disease. J Health Commun 14:768\u2013784","journal-title":"J Health Commun"},{"key":"1934_CR3","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1038\/ejhg.2010.119","volume":"18","author":"S Ashida","year":"2010","unstructured":"Ashida S, Koehly LM, Roberts JS et al (2010) The role of disease perceptions and results sharing in psychological adaptation after genetic susceptibility testing: the REVEAL Study. Eur J Hum Genet 18:1296\u20131301","journal-title":"Eur J Hum Genet"},{"key":"1934_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/ng1934","volume":"39","author":"L Bertram","year":"2007","unstructured":"Bertram L, McQueen MB, Mullin K et al (2007) Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat Genet 39:17\u201323","journal-title":"Nat Genet"},{"key":"1934_CR5","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1159\/000368888","volume":"18","author":"AG Besser","year":"2015","unstructured":"Besser AG, Sanderson SC, Roberts JS et al (2015) Factors affecting recall of different types of personal genetic information about Alzheimer\u2019s disease risk: the REVEAL study. Public Health Genom 18:78\u201386","journal-title":"Public Health Genom"},{"key":"1934_CR6","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1097\/GIM.0b013e31816b64dc","volume":"10","author":"TD Bird","year":"2008","unstructured":"Bird TD (2008) Genetic aspects of Alzheimer disease. Genet Med 10:231\u2013239","journal-title":"Genet Med"},{"key":"1934_CR7","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1212\/WNL.48.1.139","volume":"48","author":"D Blacker","year":"1997","unstructured":"Blacker D, Haines JL, Rodes L et al (1997) ApoE-4 and age at onset of Alzheimer\u2019s disease: the NIMH genetics initiative. Neurology 48:139\u2013147","journal-title":"Neurology"},{"key":"1934_CR8","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nrn2620","volume":"10","author":"G Bu","year":"2009","unstructured":"Bu G (2009) Apolipoprotein E and its receptors in Alzheimer\u2019s disease: pathways, pathogenesis and therapy. Nat Rev Neurosci 10:333","journal-title":"Nat Rev Neurosci"},{"key":"1934_CR9","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1001\/archgenpsychiatry.2011.155","volume":"69","author":"P Buchhave","year":"2012","unstructured":"Buchhave P, Minthon L, Zetterberg H et al (2012) Cerebrospinal fluid levels of \u03b2-amyloid 1\u201342, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia. Arch Gen Psychiatry 69:98\u2013106","journal-title":"Arch Gen Psychiatry"},{"key":"1934_CR10","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1111\/jgs.12292","volume":"61","author":"M Campos","year":"2013","unstructured":"Campos M, Edland SD, Peavy GM (2013) Exploratory study of apolipoprotein E \u03b54 genotype and risk of Alzheimer\u2019s disease in Mexican Hispanics. J Am Geriatr Soc 61:1038\u20131040","journal-title":"J Am Geriatr Soc"},{"key":"1934_CR11","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1056\/NEJMoa0809437","volume":"361","author":"RJ Caselli","year":"2009","unstructured":"Caselli RJ, Dueck AC, Osborne D et al (2009) Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect. N Engl J Med 361:255\u2013263","journal-title":"N Engl J Med"},{"key":"1934_CR12","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/j.mayocp.2014.05.016","volume":"89","author":"RJ Caselli","year":"2014","unstructured":"Caselli RJ, Langbaum J, Marchant GE et al (2014) Public perceptions of presymptomatic testing for Alzheimer disease. Mayo Clin Proc 89:1389\u20131396","journal-title":"Mayo Clin Proc"},{"key":"1934_CR13","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1097\/WAD.0000000000000097","volume":"29","author":"RJ Caselli","year":"2015","unstructured":"Caselli RJ, Marchant GE, Hunt KS et al (2015) Predictive testing for Alzheimer\u2019s disease: suicidal ideation in healthy participants. Alzheimer Dis Assoc Disord 29:252\u2013254","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"1934_CR14","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.jalz.2008.04.007","volume":"4","author":"MR Cassidy","year":"2008","unstructured":"Cassidy MR, Roberts JS, Bird TD et al (2008) Comparing test-specific distress of susceptibility versus deterministic genetic testing for Alzheimer\u2019s disease. Alzheimers Dement 4:406\u2013413","journal-title":"Alzheimers Dement"},{"key":"1934_CR15","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1136\/jnnp.2003.028076","volume":"75","author":"J Cervilla","year":"2004","unstructured":"Cervilla J, Prince M, Joels S et al (2004) Premorbid cognitive testing predicts the onset of dementia and Alzheimer\u2019s disease better than and independently of APOE genotype. J Neurol Neurosurg Psychiatry 75:1100\u20131106","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1934_CR16","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1097\/WAD.0b013e31815a9dcc","volume":"22","author":"S Chao","year":"2008","unstructured":"Chao S, Roberts JS, Marteau TM et al (2008) Health behavior changes after genetic risk assessment for Alzheimer disease: The REVEAL Study. Alzheimer Dis Assoc Disord 22:94\u201397","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"1934_CR17","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.neurobiolaging.2008.06.014","volume":"31","author":"C-H Chen","year":"2010","unstructured":"Chen C-H, Mizuno T, Elston R et al (2010) A comparative study to screen dementia and APOE genotypes in an ageing East African population. Neurobiol Aging 31:732\u2013740","journal-title":"Neurobiol Aging"},{"key":"1934_CR18","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/GIM.0b013e318164e4cf","volume":"10","author":"KD Christensen","year":"2008","unstructured":"Christensen KD, Roberts JS, Royal CDM et al (2008) Incorporating ethnicity into genetic risk assessment for Alzheimer disease: the REVEAL study experience. Genet Med 10:207\u2013214","journal-title":"Genet Med"},{"key":"1934_CR19","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1097\/GIM.0b013e3182076bf1","volume":"13","author":"KD Christensen","year":"2011","unstructured":"Christensen KD, Roberts JS, Uhlmann WR, Green RC (2011) Changes to perceptions of the pros and cons of genetic susceptibility testing after APOE genotyping for Alzheimer disease risk. Genet Med 13:409\u2013414","journal-title":"Genet Med"},{"key":"1934_CR20","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13073-014-0124-0","volume":"7","author":"KD Christensen","year":"2015","unstructured":"Christensen KD, Roberts JS, Zikmund-Fisher BJ et al (2015) Associations between self-referral and health behavior responses to genetic risk information. Genome Med 7:10","journal-title":"Genome Med"},{"key":"1934_CR21","doi-asserted-by":"publisher","first-page":"155","DOI":"10.7326\/M15-0187","volume":"164","author":"KD Christensen","year":"2016","unstructured":"Christensen KD, Roberts JS, Whitehouse PJ et al (2016) Disclosing pleiotropic effects during genetic risk assessment for Alzheimer disease: a randomized trial. Ann Intern Med 164:155\u2013163","journal-title":"Ann Intern Med"},{"key":"1934_CR22","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1136\/medethics-2012-101022","volume":"40","author":"DS Davis","year":"2014","unstructured":"Davis DS (2014) Alzheimer disease and pre-emptive suicide. J Med Ethics 40:543\u2013549","journal-title":"J Med Ethics"},{"key":"1934_CR23","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1136\/medethics-2013-101615","volume":"40","author":"R Dresser","year":"2014","unstructured":"Dresser R (2014) Pre-emptive suicide, precedent autonomy and preclinical Alzheimer disease. J Med Ethics 40:550\u2013551","journal-title":"J Med Ethics"},{"key":"1934_CR24","first-page":"123","volume":"19","author":"M Durnin","year":"2012","unstructured":"Durnin M, Hoy M, Ruse M, Others (2012) Genetic testing and insurance: The complexity of adverse selection. Ethical Perspect 19:123\u2013154","journal-title":"Ethical Perspect"},{"key":"1934_CR25","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1002\/ajpa.21298","volume":"143","author":"DTA Eisenberg","year":"2010","unstructured":"Eisenberg DTA, Kuzawa CW, Hayes MG (2010) Worldwide allele frequencies of the human apolipoprotein E gene: climate, local adaptations, and evolutionary history. Am J Phys Anthropol 143:100\u2013111","journal-title":"Am J Phys Anthropol"},{"key":"1934_CR26","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/gim.2016.170","volume":"19","author":"M Ekstract","year":"2017","unstructured":"Ekstract M, Holtzman GI, Kim KY et al (2017) Evaluation of a Web-based decision aid for people considering the APOE genetic test for Alzheimer risk. Genet Med 19:676\u2013682","journal-title":"Genet Med"},{"key":"1934_CR27","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1089\/gte.2007.0103","volume":"12","author":"TR Fanshawe","year":"2008","unstructured":"Fanshawe TR, Prevost AT, Roberts JS et al (2008) Explaining behavior change after genetic testing: the problem of collinearity between test results and risk estimates. Genet Test 12:381\u2013386","journal-title":"Genet Test"},{"key":"1934_CR28","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","volume":"278","author":"LA Farrer","year":"1997","unstructured":"Farrer LA, Cupples LA, Haines JL et al (1997) Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer disease meta-analysis consortium. JAMA 278:1349\u20131356","journal-title":"JAMA"},{"key":"1934_CR29","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.jalz.2007.09.005","volume":"4","author":"JE Galvin","year":"2008","unstructured":"Galvin JE, Fu Q, Nguyen JT et al (2008) Psychosocial determinants of intention to screen for Alzheimer\u2019s disease. Alzheimers Dement 4:353\u2013360","journal-title":"Alzheimers Dement"},{"key":"1934_CR30","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1056\/NEJMoa0809578","volume":"361","author":"RC Green","year":"2009","unstructured":"Green RC, Roberts JS, Cupples LA et al (2009) Disclosure of APOE genotype for risk of Alzheimer\u2019s disease. N Engl J Med 361:245\u2013254","journal-title":"N Engl J Med"},{"key":"1934_CR31","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.pec.2016.12.005","volume":"100","author":"Y Guan","year":"2017","unstructured":"Guan Y, Roter DL, Erby LH et al (2017) Disclosing genetic risk of Alzheimer\u2019s disease to cognitively impaired patients and visit companions: Findings from the REVEAL Study. Patient Educ Couns 100:927\u2013935","journal-title":"Patient Educ Couns"},{"key":"1934_CR32","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1007\/s10897-016-9965-6","volume":"25","author":"LS Hercher","year":"2016","unstructured":"Hercher LS, Caudle M, Griffin J et al (2016) Student-athletes\u2019 views on APOE genotyping for increased risk of poor recovery after a traumatic brain injury. J Genet Couns 25:1267\u20131275","journal-title":"J Genet Couns"},{"key":"1934_CR33","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1007\/s10897-008-9194-8","volume":"18","author":"S Hiraki","year":"2009","unstructured":"Hiraki S, Chen CA, Roberts JS et al (2009) Perceptions of familial risk in those seeking a genetic risk assessment for Alzheimer\u2019s disease. J Genet Couns 18:130\u2013136","journal-title":"J Genet Couns"},{"key":"1934_CR34","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/s10897-013-9627-x","volume":"23","author":"M-Y Huang","year":"2014","unstructured":"Huang M-Y, Huston SA, Perri M (2014) Consumer preferences for the predictive genetic test for Alzheimer disease. J Genet Couns 23:172\u2013178","journal-title":"J Genet Couns"},{"key":"1934_CR35","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.tibtech.2010.09.007","volume":"29","author":"C Humpel","year":"2011","unstructured":"Humpel C (2011) Identifying and validating biomarkers for Alzheimer\u2019s disease. Trends Biotechnol 29:26\u201332","journal-title":"Trends Biotechnol"},{"key":"1934_CR36","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.neuron.2009.06.026","volume":"63","author":"J Kim","year":"2009","unstructured":"Kim J, Basak JM, Holtzman DM (2009) The role of apolipoprotein E in Alzheimer\u2019s disease. Neuron 63:287\u2013303","journal-title":"Neuron"},{"key":"1934_CR37","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1097\/NMD.0000000000000154","volume":"202","author":"R Klitzman","year":"2014","unstructured":"Klitzman R, Abbate KJ, Chung WK et al (2014) Psychiatrists\u2019 views of the genetic bases of mental disorders and behavioral traits and their use of genetic tests. J Nerv Ment Dis 202:530\u2013538","journal-title":"J Nerv Ment Dis"},{"key":"1934_CR38","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1089\/gtmb.2011.0028","volume":"15","author":"IM Kopits","year":"2011","unstructured":"Kopits IM, Chen C, Roberts JS et al (2011) Willingness to pay for genetic testing for Alzheimer\u2019s disease: a measure of personal utility. Genet Test Mol Biomark 15:871\u2013875","journal-title":"Genet Test Mol Biomark"},{"key":"1934_CR39","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/ng.2802","volume":"45","author":"JC Lambert","year":"2013","unstructured":"Lambert JC, Ibrahim-Verbaas CA, Harold D et al (2013) Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease. Nat Genet 45:1452\u20131458","journal-title":"Nat Genet"},{"key":"1934_CR40","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.pec.2013.10.019","volume":"94","author":"B Lerner","year":"2014","unstructured":"Lerner B, Roberts JS, Shwartz M et al (2014) Distinct communication patterns during genetic counseling for late-onset Alzheimer\u2019s risk assessment. Patient Educ Couns 94:170\u2013179","journal-title":"Patient Educ Couns"},{"key":"1934_CR41","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1176\/appi.ajp.2013.12121590","volume":"171","author":"TT Lineweaver","year":"2014","unstructured":"Lineweaver TT, Bondi MW, Galasko D, Salmon DP (2014) Effect of knowledge of APOE genotype on subjective and objective memory performance in healthy older adults. Am J Psychiatry 171:201\u2013208","journal-title":"Am J Psychiatry"},{"key":"1934_CR42","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1097\/GIM.0b013e3181cef9e1","volume":"12","author":"E Linnenbringer","year":"2010","unstructured":"Linnenbringer E, Roberts JS, Hiraki S et al (2010) \u201cI know what you told me, but this is what I think:\u201d perceived risk of Alzheimer disease among individuals who accurately recall their genetics-based risk estimate. Genet Med 12:219\u2013227","journal-title":"Genet Med"},{"key":"1934_CR43","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","volume":"9","author":"C-C Liu","year":"2013","unstructured":"Liu C-C, Liu C-C, Kanekiyo T et al (2013) Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol 9:106\u2013118","journal-title":"Nat Rev Neurol"},{"key":"1934_CR44","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1080\/14636778.2011.552300","volume":"30","author":"DA Messner","year":"2011","unstructured":"Messner DA (2011) Informed choice in direct-to-consumer genetic testing for Alzheimer and other diseases: lessons from two cases. New Genet Soc 30:59\u201372","journal-title":"New Genet Soc"},{"key":"1934_CR45","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1002\/hec.1704","volume":"21","author":"PJ Neumann","year":"2012","unstructured":"Neumann PJ, Cohen JT, Hammitt JK et al (2012) Willingness-to-pay for predictive tests with no immediate treatment implications: a survey of US residents. Health Econ 21:238\u2013251","journal-title":"Health Econ"},{"key":"1934_CR46","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/ejhg.2008.198","volume":"17","author":"DR Nyholt","year":"2009","unstructured":"Nyholt DR, Yu C-E, Visscher PM (2009) On Jim Watson\u2019s APOE status: genetic information is hard to hide. Eur J Hum Genet 17:147\u2013149","journal-title":"Eur J Hum Genet"},{"key":"1934_CR47","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1159\/000431250","volume":"18","author":"JE Ostergren","year":"2015","unstructured":"Ostergren JE, Gornick MC, Carere DA et al (2015) How well do customers of direct-to-consumer personal genomic testing services comprehend genetic test results? Findings from the impact of personal genomics study. Public Health Genom 18:216\u2013224","journal-title":"Public Health Genom"},{"issue":"1","key":"1934_CR48","doi-asserted-by":"publisher","first-page":"Manuscript 5","DOI":"10.3912\/OJIN.Vol13No01Man05","volume":"13","author":"CT Paniagua","year":"2008","unstructured":"Paniagua CT, Taylor RE (2008) The cultural lens of genomics. OJIN Online J Issues Nurs 13(1):Manuscript 5. \n                    https:\/\/doi.org\/10.3912\/OJIN.Vol13No01Man05","journal-title":"OJIN Online J Issues Nurs"},{"key":"1934_CR49","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1503\/cmaj.070796","volume":"178","author":"C Patterson","year":"2008","unstructured":"Patterson C, Feightner JW, Garcia A et al (2008) Diagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer disease. CMAJ 178:548\u2013556","journal-title":"CMAJ"},{"key":"1934_CR50","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.pneurobio.2012.12.001","volume":"110","author":"KR Peters","year":"2013","unstructured":"Peters KR, Lynn Beattie B, Feldman HH, Illes J (2013) A conceptual framework and ethics analysis for prevention trials of Alzheimer Disease. Prog Neurobiol 110:114\u2013123","journal-title":"Prog Neurobiol"},{"key":"1934_CR51","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jalz.2012.11.007","volume":"9","author":"M Prince","year":"2013","unstructured":"Prince M, Bryce R, Albanese E et al (2013) The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement 9:63\u201375.e2","journal-title":"Alzheimers Dement"},{"key":"1934_CR52","doi-asserted-by":"publisher","first-page":"e1002254","DOI":"10.1371\/journal.pmed.1002254","volume":"14","author":"J Qian","year":"2017","unstructured":"Qian J, Wolters FJ, Beiser A et al (2017) APOE-related risk of mild cognitive impairment and dementia for prevention trials: an analysis of four cohorts. PLoS Med 14:e1002254","journal-title":"PLoS Med"},{"key":"1934_CR53","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1159\/000455006","volume":"20","author":"JS Roberts","year":"2017","unstructured":"Roberts JS, Gornick MC, Carere DA et al (2017) Direct-to-consumer genetic testing: user motivations, decision making, and perceived utility of results. Public Health Genom 20:36\u201345","journal-title":"Public Health Genom"},{"key":"1934_CR54","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1471-2377-8-9","volume":"8","author":"SB Sando","year":"2008","unstructured":"Sando SB, Melquist S, Cannon A et al (2008) APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer\u2019s disease; a case control study from central Norway. BMC Neurol 8:9","journal-title":"BMC Neurol"},{"key":"1934_CR55","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/mp.2011.136","volume":"18","author":"D Schlesinger","year":"2011","unstructured":"Schlesinger D, Grinberg LT, Alba JG et al (2011) African ancestry protects against Alzheimer\u2019s disease-related neuropathology. Mol Psychiatry 18:79","journal-title":"Mol Psychiatry"},{"key":"1934_CR56","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1007\/s10865-015-9630-9","volume":"38","author":"K Sherman","year":"2015","unstructured":"Sherman K, Shaw L-K, Champion K et al (2015) The effect of disease risk probability and disease type on interest in clinic-based versus direct-to-consumer genetic testing services. J Behav Med 38:706\u2013714","journal-title":"J Behav Med"},{"key":"1934_CR57","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1377\/hlthaff.2009.0525","volume":"29","author":"DH Taylor Jr","year":"2010","unstructured":"Taylor DH Jr, Cook-Deegan RM, Hiraki S et al (2010) Genetic testing for Alzheimer\u2019s and long-term care insurance. Health Aff 29:102\u2013108","journal-title":"Health Aff"},{"key":"1934_CR58","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/gim.2015.117","volume":"18","author":"C Cauwenberghe Van","year":"2016","unstructured":"Van Cauwenberghe C, Van Broeckhoven C, Sleegers K (2016) The genetic landscape of Alzheimer disease: clinical implications and perspectives. Genet Med 18:421\u2013430","journal-title":"Genet Med"},{"key":"1934_CR59","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.3945\/ajcn.2009.28981","volume":"91","author":"JA Vernarelli","year":"2010","unstructured":"Vernarelli JA, Roberts JS, Hiraki S et al (2010) Effect of Alzheimer disease genetic risk disclosure on dietary supplement use. Am J Clin Nutr 91:1402\u20131407","journal-title":"Am J Clin Nutr"},{"key":"1934_CR60","doi-asserted-by":"publisher","first-page":"e2698","DOI":"10.1371\/journal.pone.0002698","volume":"3","author":"S-C Wang","year":"2008","unstructured":"Wang S-C, Oelze B, Schumacher A (2008) Age-specific epigenetic drift in late-onset Alzheimer\u2019s disease. PLoS One 3:e2698","journal-title":"PLoS One"},{"key":"1934_CR61","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/alzrt206","volume":"5","author":"EM Wikler","year":"2013","unstructured":"Wikler EM, Blendon RJ, Benson JM (2013) Would you want to know? Public attitudes on early diagnostic testing for Alzheimer\u2019s disease. Alzheimers Res Ther 5:43","journal-title":"Alzheimers Res Ther"},{"key":"1934_CR62","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1093\/gerona\/glr106","volume":"66A","author":"Y Zeng","year":"2011","unstructured":"Zeng Y, Hughes CL, Lewis MA et al (2011) Interactions between life stress factors and carrying the APOE4 allele adversely impact self-reported health in old adults. J Gerontol A Biol Sci Med Sci 66A:1054\u20131061","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"1934_CR63","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/BF03256401","volume":"15","author":"NK Zgheib","year":"2011","unstructured":"Zgheib NK, Arawi T, Mahfouz RA, Sabra R (2011) Attitudes of health care professionals toward pharmacogenetic testing. Mol Diagn Ther 15:115\u2013122","journal-title":"Mol Diagn Ther"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-018-1934-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-018-1934-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-018-1934-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,31]],"date-time":"2019-10-31T00:20:59Z","timestamp":1572481259000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-018-1934-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,31]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["1934"],"URL":"https:\/\/doi.org\/10.1007\/s00702-018-1934-9","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,31]]},"assertion":[{"value":"8 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}